Bioventus (BVS) Invested Capital (2020 - 2026)

Bioventus (BVS) has 7 years of Invested Capital data on file, last reported at $461.0 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 11.59% year-over-year to $461.0 million; the trailing twelve-month figure through Mar 2026 stood at $461.0 million (down 11.59% YoY), and the FY2025 full-year result was $522.4 million, changed 0.22% from the prior year.
• Invested Capital for Q1 2026 stood at $461.0 million, down from $522.4 million in the prior quarter.
• Across five years, Invested Capital topped out at $828.8 million in Q4 2022 and bottomed at $281.7 million in Q2 2023.
• The 5-year median for Invested Capital is $555.4 million (2024), against an average of $553.4 million.
• The widest annual swing landed in 2022, when Invested Capital jumped 187.96%; it then sank 54.13% in 2023.
• A 5-year view of Invested Capital shows it stood at $828.8 million in 2022, then slipped by 27.49% to $601.0 million in 2023, then fell by 13.27% to $521.2 million in 2024, then gained by 0.22% to $522.4 million in 2025, then retreated by 11.76% to $461.0 million in 2026.
• The last three Invested Capital figures came in at $461.0 million (Q1 2026), $522.4 million (Q4 2025), and $497.1 million (Q3 2025), per Business Quant data.

Peer Comparison